Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA.
Adv Chronic Kidney Dis. 2011 Jul;18(4):243-8. doi: 10.1053/j.ackd.2011.03.002.
Proteinuria is a strong predictor of adverse cardiovascular and kidney events, and an accurate assessment of proteinuria is important for the evaluation and management of CKD. Total urinary protein can be assessed using dipstick, precipitation, and electrophoresis methods. Urinary albumin, the predominant urinary protein in most proteinuric kidney diseases, can be assessed using an albumin-specific dipstick, immunochemical techniques, and size-exclusion high-performance liquid chromatography. Urine albumin may be immune-reactive, immune-unreactive, fragmented, and biochemically modified, and laboratory techniques have variable abilities to detect different types of albumin. Urine specimen for proteinuria assessment can either be obtained from a timed-collection or a spot urine sample. Spot urine protein- or albumin-to-creatinine ratios are preferred to a 24-hour urine sample in routine practice. Assessment of albuminuria rather than proteinuria is more clinically meaningful in patients with diabetic kidney disease, and proteinuria and albuminuria assessments both have a role in nondiabetic kidney disease and in general population screening. As measurement and sampling procedures for proteinuria assessment have yet not been standardized, it is important for physicians to be aware of different types of urinary proteins, albumins, laboratory techniques, and urine sampling methods.
蛋白尿是心血管和肾脏不良事件的强烈预测因子,准确评估蛋白尿对于 CKD 的评估和管理非常重要。总尿蛋白可以使用尿沉渣检查、沉淀和电泳方法进行评估。尿白蛋白是大多数蛋白尿性肾脏疾病中主要的尿蛋白,可以使用白蛋白特异性尿沉渣检查、免疫化学技术和分子筛高效液相色谱法进行评估。尿白蛋白可能具有免疫反应性、免疫非反应性、片段化和生物化学修饰,并且实验室技术检测不同类型的白蛋白的能力各不相同。用于蛋白尿评估的尿标本可以来自定时采集或随机尿样。在常规实践中,随机尿蛋白或白蛋白与肌酐的比值优于 24 小时尿样。在糖尿病肾病患者中,评估白蛋白尿而不是蛋白尿更具临床意义,蛋白尿和白蛋白尿评估在非糖尿病肾病和一般人群筛查中均具有作用。由于蛋白尿评估的测量和采样程序尚未标准化,因此医生了解不同类型的尿蛋白、白蛋白、实验室技术和尿液采样方法非常重要。